InsiderClue
← All stocks

Chemomab Therapeutics Ltd.

CMMB Net selling
CIK 0001534248 #5140 in the set updated 17 Sep 2026
Bought (120 mo)
$194.95K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.50M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$2.50M
9 of 9 sales
Net
−$2.31M
−$2.31M against sales at will

By person

9 insiders · 32 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mor George Adi
Chief Executive Officer
$20.25K (2)
$1.28M (4)
−$1.26M
269,897
0.0469%
$755.71K
−70.9%
OrbiMed Israel GP Ltd. entity
10% owner
—
$1.21M (2)
−$1.21M
4,819,448
0.8376%
$13.49M
−1.0%
Cohen Neil Harris
Director
$147.36K (6)
$11.33K (3)
+$136.02K
33,000
0.0057%
$92.40K
+30.4%
Pfost Dale R
Chief Executive Officer
$9.94K (2)
—
+$9.94K
2,500
0.0004%
$7.00K
—
Marvin Donald
Executive VP, CFO & COO
$6.68K (7)
—
+$6.68K
2,000
0.0003%
$5.60K
+700.0%
Maryles Joel Michael
Director
$5.59K (4)
—
+$5.59K
1,433
0.0002%
$4.01K
—
Darvish Nissim
Director
$5.14K (1)
—
+$5.14K
1,200
0.0002%
$3.36K
—
THIEL PETER
10% owner
— (1)
—
$0.00
1,108,509
0.1927%
$3.10M
+26.3%
SQUINTO STEPHEN P
Director
—
—
—
47,938
0.0083%
$134.23K
0.0%

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Cohen Neil Harris
28 Aug 2026
Director
Sell
1,000
$2.80
$2.80K
Cohen Neil Harris
27 Aug 2026
Director
Sell
1,304
$2.85
$3.72K
Mor George Adi
3 Jan 2023
Chief Scientific Officer
Sell indirect
6,100
$5.03
$30.66K
Mor George Adi
3 Jan 2023
Chief Scientific Officer
Sell
7,700
$5.03
$38.71K
OrbiMed Israel GP Ltd.
3 Jan 2023
10% owner
Sell indirect
70,524
$4.51
$318.06K
OrbiMed Israel GP Ltd.
3 Jan 2023
10% owner
Sell indirect
266,376
$3.34
$889.70K
Mor George Adi
16 Nov 2022
Chief Scientific Officer
Sell indirect
257,248
$2.08
$536.31K
Mor George Adi
16 Nov 2022
Chief Scientific Officer
Sell
324,775
$2.08
$677.09K
Cohen Neil Harris
16 Nov 2022
Director
Sell
2,409
$2.00
$4.82K
Show all 32 transactions →

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 1
Shares from compensation/vesting 338,632
Sales filed before the plan box existed 7
History held since 11 Mar 2021